Filing Details
- Accession Number:
- 0001140361-12-039087
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-31 16:28:07
- Reporting Period:
- 2012-08-29
- Filing Date:
- 2012-08-31
- Accepted Time:
- 2012-08-31 16:28:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070698 | Raptor Pharmaceutical Corp | RPTP | Pharmaceutical Preparations (2834) | 860883978 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1362490 | Todd Zankel | C/O Raptor Pharmaceutical Corp. 9 Commercial Blvd., Suite 200 Novato CA 94949 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-08-29 | 10,136 | $5.01 | 659,214 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to a Rule 10b5-1 trading plan executed on January 9, 2012.
- This transaction was executed in multiple trades at prices ranging from $5.00 to $5.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
